These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 20182037

  • 21. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V, Filali M, Lessard M, Relton J, Wong G, Rivest S.
    Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
    [Abstract] [Full Text] [Related]

  • 22. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
    Chavant F, Deguil J, Pain S, Ingrand I, Milin S, Fauconneau B, Pérault-Pochat MC, Lafay-Chebassier C.
    J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
    [Abstract] [Full Text] [Related]

  • 23. beta-Secretase, APP and Abeta in Alzheimer's disease.
    Vassar R.
    Subcell Biochem; 2005 Feb; 38():79-103. PubMed ID: 15709474
    [Abstract] [Full Text] [Related]

  • 24. Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta.
    Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E, Cortes M, Volitakis I, Liu X, Smith JP, Perez K, Laughton K, Li QX, Charman SA, Nicolazzo JA, Wilkins S, Deleva K, Lynch T, Kok G, Ritchie CW, Tanzi RE, Cappai R, Masters CL, Barnham KJ, Bush AI.
    Neuron; 2008 Jul 10; 59(1):43-55. PubMed ID: 18614028
    [Abstract] [Full Text] [Related]

  • 25. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T, Kiliaan AJ, Kadish I.
    Neurobiol Dis; 2006 Sep 10; 23(3):653-62. PubMed ID: 16829076
    [Abstract] [Full Text] [Related]

  • 26. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A, Julien C, Tremblay C, Berthiaume L, Julien P, Giguère Y, Calon F.
    Neuroscience; 2009 Mar 03; 159(1):296-307. PubMed ID: 19135506
    [Abstract] [Full Text] [Related]

  • 27. Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic mice.
    Zeitlin R, Patel S, Burgess S, Arendash GW, Echeverria V.
    Brain Res; 2011 Oct 12; 1417():127-36. PubMed ID: 21907331
    [Abstract] [Full Text] [Related]

  • 28. Differential effects of gamma-secretase and BACE1 inhibition on brain Abeta levels in vitro and in vivo.
    Elvang AB, Volbracht C, Pedersen LØ, Jensen KG, Karlsson JJ, Larsen SA, Mørk A, Stensbøl TB, Bastlund JF.
    J Neurochem; 2009 Sep 12; 110(5):1377-87. PubMed ID: 19519664
    [Abstract] [Full Text] [Related]

  • 29. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes.
    Sterniczuk R, Dyck RH, Laferla FM, Antle MC.
    Brain Res; 2010 Aug 12; 1348():139-48. PubMed ID: 20471965
    [Abstract] [Full Text] [Related]

  • 30. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
    Wu ZL, Ciallella JR, Flood DG, O'Kane TM, Bozyczko-Coyne D, Savage MJ.
    Neurobiol Aging; 2006 Mar 12; 27(3):377-86. PubMed ID: 15927307
    [Abstract] [Full Text] [Related]

  • 31. Use of multimetric statistical analysis to characterize and discriminate between the performance of four Alzheimer's transgenic mouse lines differing in Abeta deposition.
    Leighty RE, Nilsson LN, Potter H, Costa DA, Low MA, Bales KR, Paul SM, Arendash GW.
    Behav Brain Res; 2004 Aug 12; 153(1):107-21. PubMed ID: 15219712
    [Abstract] [Full Text] [Related]

  • 32. Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms.
    Costa DA, Cracchiolo JR, Bachstetter AD, Hughes TF, Bales KR, Paul SM, Mervis RF, Arendash GW, Potter H.
    Neurobiol Aging; 2007 Jun 12; 28(6):831-44. PubMed ID: 16730391
    [Abstract] [Full Text] [Related]

  • 33. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
    Hussain I, Hawkins J, Harrison D, Hille C, Wayne G, Cutler L, Buck T, Walter D, Demont E, Howes C, Naylor A, Jeffrey P, Gonzalez MI, Dingwall C, Michel A, Redshaw S, Davis JB.
    J Neurochem; 2007 Feb 12; 100(3):802-9. PubMed ID: 17156133
    [Abstract] [Full Text] [Related]

  • 34. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.
    Prediger RD, Medeiros R, Pandolfo P, Duarte FS, Passos GF, Pesquero JB, Campos MM, Calixto JB, Takahashi RN.
    Neuroscience; 2008 Feb 06; 151(3):631-43. PubMed ID: 18191900
    [Abstract] [Full Text] [Related]

  • 35. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice.
    Rezai-Zadeh K, Arendash GW, Hou H, Fernandez F, Jensen M, Runfeldt M, Shytle RD, Tan J.
    Brain Res; 2008 Jun 12; 1214():177-87. PubMed ID: 18457818
    [Abstract] [Full Text] [Related]

  • 36. Crude caffeine reduces memory impairment and amyloid β(1-42) levels in an Alzheimer's mouse model.
    Chu YF, Chang WH, Black RM, Liu JR, Sompol P, Chen Y, Wei H, Zhao Q, Cheng IH.
    Food Chem; 2012 Dec 01; 135(3):2095-102. PubMed ID: 22953961
    [Abstract] [Full Text] [Related]

  • 37. Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice.
    Cao C, Cirrito JR, Lin X, Wang L, Verges DK, Dickson A, Mamcarz M, Zhang C, Mori T, Arendash GW, Holtzman DM, Potter H.
    J Alzheimers Dis; 2009 Dec 01; 17(3):681-97. PubMed ID: 19581723
    [Abstract] [Full Text] [Related]

  • 38. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 2. Behavioral and cognitive changes.
    Sterniczuk R, Antle MC, Laferla FM, Dyck RH.
    Brain Res; 2010 Aug 12; 1348():149-55. PubMed ID: 20558146
    [Abstract] [Full Text] [Related]

  • 39. Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease.
    Wang J, Ho L, Zhao Z, Seror I, Humala N, Dickstein DL, Thiyagarajan M, Percival SS, Talcott ST, Pasinetti GM.
    FASEB J; 2006 Nov 12; 20(13):2313-20. PubMed ID: 17077308
    [Abstract] [Full Text] [Related]

  • 40. Anti-Alzheimer's disease potential of Arabian coffee versus Date palm seed extract in male rats.
    Zidan NS, Omran AME, Rezk SM, Atteia HH, Sakran MI.
    J Food Biochem; 2022 Jan 12; 46(1):e14017. PubMed ID: 34816451
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.